Exam 3 Blueprint | Study Guide

**CONCEPT**  **TOPIC/DRUG CLASS**  **FOCUS**  **OUTCOMES MEASURED**  -------------------------- -------------------------------------------------------- ------------------------------------------------...

**CONCEPT**  **TOPIC/DRUG CLASS**  **FOCUS**  **OUTCOMES MEASURED**  -------------------------- -------------------------------------------------------- ---------------------------------------------------------- ------------------------ Hormonal Regulation Cushing Syndrome Assessment MO1 Hormonal Regulation Graves Disease Assessment MO1 Hormonal Regulation Hormonal Regulation Mechanism MO1 Hormonal Regulation Syndrome of Inappropriate Antidiuretic Hormone (SIADH) Monitoring MO1 Glucose Regulation Hyperglycemia Assessment MO1 Glucose Regulation Diabetes Mellitus (DM) Type 2 Risk Factors MO2 Glucose Regulation Diabetes Mellitus (DM) Type 1 Physiologic Process MO1 Glucose Regulation Glucose Regulation N/A MO1 Elimination Ulcerative Colitis Assessment MO1 Elimination Hydronephrosis N/A MO1 Elimination Incontinence Consequences MO1 Nutrition Vitamin Deficiencies N/A MO1 Nutrition Obesity Assessment MO1 Immunity Secondary Response Physiologic Process MO2 Immunity Immunoglobulins Identification MO2 Immunity Immune Response Immune Response Types MO2 Immunity Immunosuppression Consequences MO1 Cellular Regulation Cellular Regulation N/A MO1 Cellular Regulation Malignancy Classification MO2 Cellular Regulation Cellular Adaptation Identification MO2 Elimination Meds Antacids Patient Education MO8 Elimination Meds Bulk-Forming Laxatives Patient Education MO8 Elimination Meds Laxatives Indications, Promote Safety MO1, MO7 Elimination Meds Laxatives Lifespan Considerations, Precautions & Contraindications MO2, MO3 Elimination Meds Phenothiazines - Promethazine Promote Safety, Lifespan Considerations M02, MO7 Elimination Meds Bismuth Subsalicylate (Pepto-Bismol) MOA MO1 Elimination Meds Peptic Ulcer Disease (H. pylori) Prioritization, Patient Education MO8 Elimination Meds Proton Pump Inhibitors (PPIs) Therapeutic Effect MO1 Elimination Meds Gastroesophageal Reflux Disease (GERD) Precautions & Contraindications, Lifespan Considerations MO2, MO3 Elimination Meds Antacids Nursing Considerations MO5 Glucose Regulation Meds Short-Acting Insulin Monitoring, Promote Safety MO6, MO7 Glucose Regulation Meds Insulin Secretagogues - Meglitinides MOA MO1 Glucose Regulation Meds Long-Acting Insulin Therapeutic Effect MO1 Glucose Regulation Meds a-Glucosidase Inhibitors MOA MO1 Glucose Regulation Meds GLP-1 Analog Therapeutic Effects MO1 Glucose Regulation Meds Insulin Monitoring MO6 Cellular Regulation Meds Anti-Neoplastic Drugs MOA MO1 Cellular Regulation Meds Chemotherapy Monitoring MO6 Cellular Regulation Meds Chemotherapy Adverse Effects, Nursing Considerations MO4, MO5 Cellular Regulation Meds Alkylating Agents Monitoring, Promote Safety MO6, MO7 Meds Affecting Immunity Immunosuppressant Patient Education MO8 Meds Affecting Immunity Toxoids MOA MO1 Meds Affecting Immunity Influenza Vaccine Precautions & Contraindications MO2 Meds Affecting Immunity Immunosuppressant Precautions & Contraindications MO2 Meds Affecting Immunity Live Virus Vaccines Lifespan Considerations MO3 Meds Affecting Immunity Immune Globulin Patient Education MO8 Hormonal Regulation Meds Hypothyroidism - Levothyroxine Lifespan Considerations MO3 Hormonal Regulation Meds Hypothyroidism - Levothyroxine Patient Education MO8 Hormonal Regulation Meds Hyperthyroidism Pharmacologic Treatment MO1 Hormonal Regulation Meds Propylthiouracil (PTU) MOA MO1